1. Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127–205, 1984
2. Baum M and other members of the Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen adjuvant agent in management of early breast cancer. Lancet 1: 257–261, 1983
3. Baum M and other members of the Nolvadex Adjuvant Trial Organization: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1: 836–840, 1985
4. Fisher B, Brown A, Wolmark N, Redmond C, Wickerham L, Wittliff J, Dimitrov N, Legault-Poisson S, Schipper H, Prager D and other NSASP investigators prolonging tamoxifen therapy for primary breast cancer: Ann Int Med 106: 649–654, 1987
5. National Institutes of Health consensus development panel on adjuvant chemotherapy and endocrine therapy for breast cancer: Introduction and conclusions, NCI Monographs 1: 1–14, 1986